| 2025-11-14 |
详情>>
股本变动：
变动后总股本516.04万股
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-4.35美元,归母净利润-723.88万美元,同比去年增长-31.83%
|
| 2025-10-20 |
股东大会：
将于2025-11-12召开股东大会
会议内容 ▼▲
- 1.To approve, pursuant to Nasdaq Rule 5635(a) and (b), the transactions provided for in that certain Subscription Agreement dated September 19, 2025, between the Company and certain investors, and related agreements, including the issuance of 337,432 shares of the Company’s common stock and 39,943 shares of the Company’s Series B Convertible Preferred Stock sold in a private placement transaction (the “Offering”).
2.To approve, pursuant to Nasdaq Rule 5635(d), the issuance of shares of the Company’s common stock upon the conversion of the Series B Convertible Preferred Stock in excess of the 19.99% share exchange cap contained therein.
3.To approve the Company’s 2025 Equity Incentive Plan.
4.To approve adjournments or postponements of the Special Meeting or to transact such other business as may be properly brought before the Special Meeting.
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-2.76美元,归母净利润-433.32万美元,同比去年增长-18.09%
|
| 2025-07-21 |
详情>>
业绩披露：
2025年一季报每股收益-1.82美元,归母净利润-264.62万美元,同比去年增长-26.44%
|
| 2025-07-16 |
复牌提示：
2025-07-16 09:43:16 停牌，复牌日期 2025-07-16 09:48:16
|
| 2025-06-30 |
详情>>
业绩披露：
2024年年报每股收益-17.55美元,归母净利润-634.68万美元,同比去年增长52.70%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-24.93美元,归母净利润-549.1万美元,同比去年增长49.93%
|
| 2024-11-05 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2024-09-10 |
股东大会：
将于2024-10-25召开股东大会
会议内容 ▼▲
- 1.To elect as directors the five nominees identified in the proxy statement;
2.To ratify the appointment of WithumSmith+Brown, PC (“Withum”) as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the outstanding shares of the Company’s common stock, at a ratio within a range of 1-for-10 to 1-for-50, with the exact ratio to be determined by the Company’s Board and included in a public announcement (the “Reverse Stock Split Proposal”)
4.To approve the adjournment of the 2024 Annual Meeting of Stockholders to a later date, or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve Proposal 3;
5.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance to each of Alpha Capital Anstalt (“Alpha”) and Yi Hua Chen (“Chen”) of more than 20% of the Company’s issued and outstanding common stock pursuant to the terms and conditions of (a) the 8% Senior Convertible Debentures Due December 31, 2024, in favor of Alpha, (b) the Company’s common stock purchase warrant dated February 27, 2024 issued to Alpha, (c) the 8% Convertible Debenture Due December 31, 2024 in favor of Chen, and (d) the Company’s common stock purchase warrant dated April 12, 2024 issued to Chen.
6.To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.54美元,归母净利润-366.93万美元,同比去年增长49.81%
|
| 2024-07-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.35美元,归母净利润-209.28万美元,同比去年增长45.59%
|
| 2024-04-08 |
详情>>
业绩披露：
2023年年报每股收益-2.65美元,归母净利润-1341.72万美元,同比去年增长28.02%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.18美元,归母净利润-1096.7万美元,同比去年增长10.61%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-1.46美元,归母净利润-731.04万美元,同比去年增长13.42%
|
| 2023-06-02 |
股东大会：
将于2023-07-13召开股东大会
会议内容 ▼▲
- 1.To elect as directors the six nominees identified in the proxy statement;
2.To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance to Alpha Capital Anstalt (“Alpha”) of more than 20% of the Company’s issued and outstanding common stock pursuant to the terms and conditions of (a) the 8% Senior Convertible Debenture Due December 22, 2025 in favor of Alpha, and (b) the Company’s common stock purchase warrant dated December 22, 2022 issued to Alpha;
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
|
| 2022-11-23 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2022-07-13 |
股东大会：
将于2022-08-25召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees identified in the proxy statement.
2.To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
3.To approve our 2022 Employee Stock Purchase Plan.
4.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the outstanding shares of the Company’s common stock, at a ratio within a range of 1-for-5 to 1-for-10, as determined by our board of directors.
5.To approve the adjournment of the Annual Meeting of Stockholders to a later date, or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve Proposal 4.
6.To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
|
| 2022-06-22 |
详情>>
内部人交易：
Poirier Michael S.股份增加30000.00股
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-07-15召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees identified in the proxy statement.
2.To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
3.To approve an amendment to our 2020 Stock Incentive Plan, to increase the number of shares of our common stock reserved under the 2020 Stock Incentive Plan by 3,500,000 shares, or from 4,057,157 shares to 7,557,157 shares.
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
5.To approve, on a non-binding, advisory basis, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers.
|
| 2020-05-26 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2019-04-26 |
股东大会：
将于2019-06-14召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees identified in the proxy statement.
2.To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
|
| 2018-05-15 |
股东大会：
将于2018-06-26召开股东大会
会议内容 ▼▲
- 1. To elect as directors the seven nominees identified in the proxy statement.
2. To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
|
| 2018-03-22 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2017-12-01 |
股东大会：
将于2017-12-20召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, that effects a reverse stock split of the outstanding shares of our common stock, at a ratio within a range of 1-for-8 to 1-for-15, as determined by our board of directors (the “Reverse Stock Split Proposal”).
2.To approve a proposal to adjourn the Special Meeting, if necessary, to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal.
|
| 2017-08-25 |
股东大会：
将于2017-09-08召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from 25,000,000 shares to 225,000,000 shares and authorized shares of preferred stock from 5,000,000 shares to 15,000,000 shares (the “Authorized Share Increase Proposal”).
2.Contingent upon the approval of the Authorized Share Increase Proposal, to approve the amendment of our 2015 Equity Incentive Plan, to (i) increase the number of shares that we may issue pursuant to awards under the 2015 Equity Incentive Plan by 25,858,711 shares to an aggregate of (i) 27,500,000 shares plus (ii) any shares which were available for grant under the 2008 Stock Plan and the 2009 Stock Plan (collectively, the “Prior Plans”) on the effective date of the 2015 Equity Incentive Plan or were subject to awards under Prior Plans which, after the effective date of the 2015 Plan, were or are forfeited or lapse unexercised or were or are settled in cash and are not issued under the Prior Plans and (b) increase the number of shares that may be issued under the 2015 Equity Incentive Plan pursuant to incentive stock options intended to qualify under Section 422 of the Code by 25,858,711 shares to 27,500,000 shares; and (c) increase the maximum aggregate number of shares with respect to one or more stock awards that may be granted to any one person during a calendar year from 300,000 shares to 3,000,000 shares.
3.To approve a proposal to adjourn the Special Meeting, if necessary, to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve the Authorized Share Increase Proposal.
|
| 2017-04-21 |
股东大会：
将于2017-06-02召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eight nominees identified in the proxy statement.
2.To ratify the appointment of Mayer Hoffman McCann P.C., as our independent registered public accounting firm for the fiscal year ending December 31, 2017.
3.To approve the amendment of the Company’s 2015 Equity Incentive Plan, in substantially the form of Annex A to this proxy statement, to increase the number of shares that may be issued pursuant to awards thereunder by 838,000 shares to an aggregate of (i) 1,641,289 shares plus (ii) any shares that were available for grant under the 2008 Stock Plan and the 2009 Stock Plan (collectively, the “Prior Plans”) on the effective date of the 2015 Equity Incentive Plan or were subject to awards under the Prior Plans that, after the effective date of the 2015 Equity Incentive Plan, were or are forfeited or lapse unexercised or were or are settled in cash and are not issued under the Prior Plans.
|
| 2016-04-21 |
股东大会：
将于2016-06-03召开股东大会
会议内容 ▼▲
- 1.To elect seven members to the board of directors of the Company.
2.To ratify the appointment of Mayer Hoffman McCann P.C., as our independent registered public accounting firm for the fiscal year ending December 31, 2016.
3.To approve the amendment of the Company’s 2015 Equity Incentive Plan in substantially the form of Annex A to the proxy statement for the 2016 Annual Meeting of Stockholders to (a) increase the number of shares that may be issued pursuant to awards thereunder by 475,000 shares to an aggregate of (i) 803,289 shares plus (ii) any shares which were available for grant under the 2008 Stock Plan and the 2009 Stock Plan (collectively, the “Prior Plans”) on the effective date of the 2015 Equity Incentive Plan or were subject to awards under the Prior Plans which, after the effective date of the 2015 Equity Incentive Plan, were or are forfeited or lapse unexercised or were or are settled in cash and are not issued under the Prior Plans; (b) increase the number of shares that may be issued under the 2015 Equity Incentive Plan pursuant to incentive stock options intended to qualify under Section 422 of the Internal Revenue Code by 475,000 shares to an aggregate of 803,289 shares; and (c) increase the maximum aggregate number of shares with respect to one or more stock awards that may be granted to any one person during a calendar year from 65,657 shares to 300,000 shares.
4.To transact such other business as may properly come before the Annual Meeting and any postponement(s) or adjournment(s) thereof.
|